CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 36.45
-0.80 (-2.15%)
Mar 3, 2025, 4:08 PM HKT
CanSino Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 12,603 | 11,610 | 12,491 | 27,690 | 66,111 | 74,412 | Upgrade
|
| Market Cap Growth | -7.06% | -7.06% | -54.89% | -58.12% | -11.16% | 466.94% | Upgrade
|
| Enterprise Value | 11,347 | 10,302 | 10,588 | 23,868 | 58,920 | 68,404 | Upgrade
|
| Last Close Price | 36.45 | 31.50 | 23.55 | 66.75 | 177.89 | 174.24 | Upgrade
|
| PE Ratio | - | - | - | - | 28.13 | - | Upgrade
|
| Forward PE | - | - | - | - | 11.16 | 25.30 | Upgrade
|
| PS Ratio | 10.02 | 12.89 | 31.75 | 23.67 | 12.53 | 2517.38 | Upgrade
|
| PB Ratio | 1.66 | 2.15 | 2.14 | 3.38 | 6.30 | 10.32 | Upgrade
|
| P/TBV Ratio | 2.21 | 2.21 | 2.21 | 3.75 | 6.88 | 10.38 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 63.60 | - | Upgrade
|
| P/OCF Ratio | - | - | - | - | 26.27 | - | Upgrade
|
| EV/Sales Ratio | 12.60 | 11.44 | 26.92 | 20.41 | 11.16 | 2314.14 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 25.96 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 26.91 | - | Upgrade
|
| EV/FCF Ratio | - | - | - | - | 56.68 | - | Upgrade
|
| Debt / Equity Ratio | 0.42 | 0.42 | 0.51 | 0.37 | 0.16 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.74 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 1.62 | - | Upgrade
|
| Asset Turnover | - | - | 0.03 | 0.09 | 0.46 | 0.01 | Upgrade
|
| Inventory Turnover | - | - | 1.55 | 1.57 | 2.48 | 0.16 | Upgrade
|
| Quick Ratio | - | - | 1.86 | 2.33 | 2.78 | 12.54 | Upgrade
|
| Current Ratio | - | - | 2.02 | 2.64 | 3.25 | 13.24 | Upgrade
|
| Return on Equity (ROE) | -7.32% | -7.32% | -31.40% | -12.22% | 26.09% | -10.52% | Upgrade
|
| Return on Assets (ROA) | - | - | -10.36% | -8.03% | 11.98% | -7.58% | Upgrade
|
| Return on Capital (ROIC) | -3.10% | -3.10% | -12.01% | -9.43% | 13.82% | -8.24% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | - | - | 19.79% | - | Upgrade
|
| Earnings Yield | -3.20% | -3.47% | -13.08% | -3.71% | 3.55% | -0.63% | Upgrade
|
| FCF Yield | - | -13.39% | -11.95% | 1.57% | -1.02% | Upgrade
| |
| Dividend Yield | 0.00% | - | - | - | 0.55% | - | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | 0.74% | - | Upgrade
|
| Buyback Yield / Dilution | -0.38% | -0.38% | 0.17% | 0.08% | -7.26% | -11.79% | Upgrade
|
| Total Shareholder Return | -0.38% | -0.38% | 0.17% | 0.08% | -6.70% | -11.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.